Uwe Pleyer

10.7k total citations
363 papers, 6.6k citations indexed

About

Uwe Pleyer is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Uwe Pleyer has authored 363 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Ophthalmology, 72 papers in Radiology, Nuclear Medicine and Imaging and 69 papers in Rheumatology. Recurrent topics in Uwe Pleyer's work include Ocular Diseases and Behçet’s Syndrome (158 papers), Retinal and Optic Conditions (69 papers) and Ocular Surface and Contact Lens (60 papers). Uwe Pleyer is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (158 papers), Retinal and Optic Conditions (69 papers) and Ocular Surface and Contact Lens (60 papers). Uwe Pleyer collaborates with scholars based in Germany, United States and Switzerland. Uwe Pleyer's co-authors include Eckart Bertelmann, Stefan Mergler, Christian Hartmann, Dirk Schlüter, Uwe Groß, Peter Rieck, Peter S. Reinach, Bartly J. Mondino, Thomas Ritter and H. Baatz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Uwe Pleyer

344 papers receiving 6.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Pleyer Germany 41 3.0k 1.5k 1.5k 1.0k 884 363 6.6k
Marc Labétoulle France 34 1.8k 0.6× 1.3k 0.9× 2.9k 1.9× 691 0.7× 1.1k 1.2× 199 6.9k
Yuichi Ohashi Japan 44 3.4k 1.1× 3.0k 2.0× 3.6k 2.4× 971 1.0× 816 0.9× 299 7.7k
James P. McCulley United States 48 3.9k 1.3× 2.9k 1.9× 4.5k 3.0× 889 0.9× 933 1.1× 190 7.7k
Gary N. Foulks United States 47 3.7k 1.2× 3.2k 2.1× 6.7k 4.5× 328 0.3× 525 0.6× 115 8.5k
Narsing A. Rao United States 50 7.1k 2.3× 895 0.6× 520 0.3× 864 0.9× 2.0k 2.2× 264 9.3k
Barbara Detrick United States 41 1.7k 0.6× 553 0.4× 354 0.2× 1.4k 1.4× 923 1.0× 111 5.3k
Esen K. Akpek United States 43 3.4k 1.1× 3.1k 2.0× 5.5k 3.7× 297 0.3× 364 0.4× 186 8.1k
Pedram Hamrah United States 49 3.1k 1.0× 4.2k 2.7× 6.0k 4.0× 634 0.6× 558 0.6× 246 8.4k
Chie Sotozono Japan 54 2.5k 0.8× 5.3k 3.5× 4.0k 2.7× 1.2k 1.2× 681 0.8× 364 10.2k
John J. Hooks United States 43 1.9k 0.6× 669 0.4× 303 0.2× 1.6k 1.6× 968 1.1× 118 5.7k

Countries citing papers authored by Uwe Pleyer

Since Specialization
Citations

This map shows the geographic impact of Uwe Pleyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Pleyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Pleyer more than expected).

Fields of papers citing papers by Uwe Pleyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Pleyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Pleyer. The network helps show where Uwe Pleyer may publish in the future.

Co-authorship network of co-authors of Uwe Pleyer

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Pleyer. A scholar is included among the top collaborators of Uwe Pleyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Pleyer. Uwe Pleyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rübsam, Anne, et al.. (2024). Adalimumab Autoantibodies in Uveitis Patients: Do We Need Routine Drug Monitoring?. Biomedicines. 12(12). 2782–2782. 1 indexed citations
2.
Iselin, Katja, Jesper Hjortdal, W. John Armitage, et al.. (2024). Outcomes after reversed corneal graft rejection: a report from the European VISICORT project. BMJ Open Ophthalmology. 9(1). e001554–e001554.
3.
4.
Schulze, Daniel, et al.. (2024). Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis. Journal of Ophthalmic Inflammation and Infection. 14(1). 61–61. 2 indexed citations
5.
Pleyer, Uwe, Carlos Pavésio, Elisabetta Miserocchi, et al.. (2024). Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. Journal of Ophthalmic Inflammation and Infection. 14(1). 22–22. 4 indexed citations
6.
Valtink, Monika, et al.. (2023). L-Carnitine Suppresses Transient Receptor Potential Vanilloid Type 1 Activation in Human Corneal Epithelial Cells. International Journal of Molecular Sciences. 24(14). 11815–11815. 9 indexed citations
7.
Doan, Serge, Nikolaos G. Papadopoulos, Jason K. Lee, et al.. (2023). Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab. World Allergy Organization Journal. 16(6). 100788–100788. 7 indexed citations
8.
Rademacher, Judith, Torsten Diekhoff, Hildrun Haibel, et al.. (2022). Keep an Eye on the Back: Spondyloarthritis in Patients With Acute Anterior Uveitis. Arthritis & Rheumatology. 75(2). 210–219. 18 indexed citations
9.
Valtink, Monika, Peter S. Reinach, Huan Luo, et al.. (2021). L-carnitine suppresses transient receptor potential vanilloid type 1 activity and myofibroblast transdifferentiation in human corneal keratocytes. Laboratory Investigation. 101(6). 680–689. 11 indexed citations
10.
Güell, José L., Anders Behndig, Uwe Pleyer, et al.. (2019). Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery. SHILAP Revista de lepidopterología.
11.
Pleyer, Uwe, Volker Klauß, Hendrik Wilking, & Martin M. Nentwich. (2016). [Tropical ophthalmology : Intraocular inflammation caused by "new" infectious pathogens and travel-related infections].. PubMed. 113(1). 35–46. 2 indexed citations
12.
Pleyer, Uwe & Soon-Phaik Chee. (2015). Current aspects on the management of viral uveitis in immunocompetent individuals. Clinical ophthalmology. 1017–1017. 49 indexed citations
13.
Worm, Margitta, et al.. (2014). Rituximab for treatment refractory ocular cicatricial pemphigoid (OCP). Investigative Ophthalmology & Visual Science. 55(13). 1494–1494.
14.
Behndig, Anders, Béatrice Cochener, José L. Güell, et al.. (2013). Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns in 9 European countries. Journal of Cataract & Refractive Surgery. 39(9). 1421–1431. 77 indexed citations
15.
Pleyer, Uwe, Matthias K. J. Klamann, Sibylle Winterhalter, & Stephan Thurau. (2012). Ozurdex: A new therapeutic option in uveitis - Clinical outcome from two German uveitis centers. Investigative Ophthalmology & Visual Science. 53(14). 2249–2249. 3 indexed citations
16.
Mergler, Stefan, Monika Valtink, Katrin Engelmann, & Uwe Pleyer. (2008). New Insights Into Electrophysiology and Functional Transient Receptor Potential (Trp) Channel Expression in the Corneal Endothelium. Investigative Ophthalmology & Visual Science. 49(13). 3939–3939. 1 indexed citations
17.
Pleyer, Uwe & R. Keitzer. (2005). [Uveitis in childhood. Small patients--big problems].. Der Ophthalmologe. 102(5). 461–462. 1 indexed citations
18.
Pleyer, Uwe, Leena Bruckner‐Tuderman, A. Friedmann, et al.. (1996). The immunology of bullous oculo-muco-cutaneous disorders. Immunology Today. 17(3). 111–113. 7 indexed citations
19.
Grammer, Joachim, et al.. (1995). Ophthalmomyiasis externa due to the sheep botfly Oestrus ovis (Diptera: Oestridae) in southwest Germany.. PubMed. 4(3). 188–95. 23 indexed citations
20.
Pleyer, Uwe, et al.. (1993). Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye.. PubMed. 34(9). 2737–42. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Labétoulle Breakdown of academic impact, for papers by Yuichi Ohashi Breakdown of academic impact, for papers by James P. McCulley Breakdown of academic impact, for papers by Gary N. Foulks Breakdown of academic impact, for papers by Narsing A. Rao Breakdown of academic impact, for papers by Barbara Detrick Breakdown of academic impact, for papers by Esen K. Akpek Breakdown of academic impact, for papers by Pedram Hamrah Breakdown of academic impact, for papers by Chie Sotozono Breakdown of academic impact, for papers by John J. Hooks
Rankless by CCL
2026